Design and Optimization of Targeted Nanoparticles for Delivery of Quercetin from Allium Cepa for Treatment of Colorectal Cancer
DOI:
https://doi.org/10.52783/jns.v14.3139Keywords:
Quercetin, Allium cepa, colorectal cancer, targeted nanoparticles, PLGA, folic acid, Box-Behnken designAbstract
Introduction: The development of effective and tailored therapy options is crucial, as colorectal cancer (CRC) continues to be a top cause of cancer-related mortality globally. The flavonoid quercetin has strong anticancer effects but is quickly metabolized and has low bioavailability. It is derived from the onion plant Allium cepa. In order to improve the treatment effectiveness against CRC while reducing systemic toxicity, this work seeks to develop and optimize tailored nanoparticles for quercetin delivery.
Materials and Methods: Solvent evaporation was used to formulate quercetin-loaded nanoparticles (NPs) utilizing poly(lactic-co-glycolic acid) (PLGA) as the polymeric matrix. The formulation parameters that were optimized using a Box-Behnken design were the concentration of polymer (50-150 mg), the concentration of surfactant (0.5-1.5% w/v), and the stirring speed (5000-15000 rpm). The response variables included particle size, entrapment efficiency, and drug release. In order to actively target CRC cells that overexpress folate receptors, the nanoparticles were surface-functionalized with folic acid. Drug loading, in vitro drug release, surface morphology, zeta potential, particle size analysis (DLS), and PBS (pH 7.4) were all part of the characterization process. Researchers used HT-29 colorectal cancer cells to study cytotoxicity and cellular uptake; flow cytometry was used to evaluate apoptosis.
Results: The optimized nanoparticles demonstrated a sustained drug release profile for 48 hours, an entrapment efficiency of 87.6 ± 3.2%, and a particle size of 165.4 ± 5.8 nm. Conjugation of folic acid into NPs increased cellular absorption 2.5-fold over non-targeted NPs. The IC₅₀ value of 18.2 µM for targeted NPs was found to be much lower than that of free quercetin (42.5 µM), suggesting that the therapeutic efficacy was increased, according to cytotoxicity studies. Compared to free quercetin, which had a cell death rate of 29.4 percent, apoptosis research showed that treated CRC cells had a cell death rate of 63.7 percent.
Conclusion: Enhanced cytotoxicity, effective targeted delivery, and apoptotic induction in CRC cells were all shown by the optimized nanoparticles loaded with quercetin. The use of this tailored nanocarrier system to enhance quercetin's therapeutic potential in the treatment of colorectal cancer is an encouraging development. These results need to be confirmed by more in vivo investigations.
Downloads
Metrics
References
Rashedi J, Ghorbani Haghjo A, Mesgari Abbasi M, Dastranj Tabrizi A, Yaqoubi S, Sanajou D, et al. Anti-tumor effect of quercetin loaded chitosan nanoparticles on induced colon cancer in Wistar rats. Adv Pharm Bull. 2019;9(3):409–15.
Suner SS, Sahiner M, Mohapatra S, Ayyala RS, Bhethanabotla VR, Sahiner N. Degradable poly(catechin) nanoparticles as a versatile therapeutic agent. Int J Polym Mater Polym Biomater. 2021;71(13):1104–15.
Yaghoubi N, Gholamzad A, Naji T, Gholamzad M. In vitro evaluation of PLGA loaded hesperidin on colorectal cancer cell lines: An insight into nano delivery system. BMC Biotechnol. 2024;24(1):52.
Castaño M, Martínez E, Osorio M, Castro C. Development of genistein drug delivery systems based on bacterial nanocellulose for potential colorectal cancer chemoprevention: Effect of nanocellulose surface modification on genistein adsorption. Molecules. 2022;27(22):7201.
Wu G, Li J, Yue J, Zhang S, Yunusi K. Liposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma. Mol Med Rep. 2018;17(2):2456–64.
Shinde P, Agraval H, Singh A, Yadav UCS, Kumar U. Synthesis of luteolin loaded zein nanoparticles for targeted cancer therapy improving bioavailability and efficacy. J Drug Deliv Sci Technol. 2019;52:369–78.
Banerjee K, Banerjee S, Mandal M. Enhanced chemotherapeutic efficacy of apigenin liposomes in colorectal cancer based on flavone-membrane interactions. J Colloid Interface Sci. 2017;491:98–110.
Yang B, Mao Y, Zhang Y, Hao Y, Guo M, Li B, et al. HA-coated PLGA nanoparticles loaded with apigenin for colon cancer with high expression of CD44. Molecules. 2023;28(15):7565.
Nobahari M, Shahanipour K, Fatahian S, Monajemi R. Evaluation of cytotoxic activity of loaded catechin into iron oxide nanoparticles coated with sodium alginate and hydroxyapatite against human HT-29 colon adenocarcinoma and breast cancer MCF-7 cells. Russ J Bioorg Chem. 2023;49(7):1049–58.
Bhattacharya S, Sangave PC, Belemkar S, Anjum MM. pH-Sensitive nanoparticles of epigallocatechin-3-gallate in enhanced colorectal cancer therapy. Nanomedicine. 2024;19(6):459–81.
Enin HAA, Alquthami AF, Alwagdani AM, Yousef LM, Albuqami MS, Alharthi MA, et al. Utilizing TPGS for optimizing quercetin nanoemulsion for colon cancer cells inhibition. Colloids Interfaces. 2022;6(3):49.
Xu G, Shi H, Ren L, Gou H, Gong D, Gao X, et al. Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles. Int J Nanomedicine. 2015;10:2051–63.
Sunoqrot S, Abujamous L. pH-Sensitive polymeric nanoparticles of quercetin as a potential colon cancer-targeted nanomedicine. J Drug Deliv Sci Technol. 2019;52:670–6.
Chen Y, Wu Q, Song L, He T, Li Y, Li L, et al. Polymeric micelles encapsulating fisetin improve the therapeutic effect in colon cancer. ACS Appl Mater Interfaces. 2015;7(1):534–42.
Rashedi J, Ghorbani Haghjo A, Mesgari Abbasi M, Dastranj Tabrizi A, Yaqoubi S, Sanajou D, et al. Anti-tumor effect of quercetin loaded chitosan nanoparticles on induced colon cancer in Wistar rats. Adv Pharm Bull. 2019;9(3):409–15.
Wu G, Li J, Yue J, Zhang S, Yunusi K. Liposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma. Mol Med Rep. 2018;17(2):2456–64.
Shinde P, Agraval H, Singh A, Yadav UCS, Kumar U. Synthesis of luteolin loaded zein nanoparticles for targeted cancer therapy improving bioavailability and efficacy. J Drug Deliv Sci Technol. 2019;52:369–78.
Banerjee K, Banerjee S, Mandal M. Enhanced chemotherapeutic efficacy of apigenin liposomes in colorectal cancer based on flavone-membrane interactions. J Colloid Interface Sci. 2017;491:98–110.
Yang B, Mao Y, Zhang Y, Hao Y, Guo M, Li B, et al. HA-coated PLGA nanoparticles loaded with apigenin for colon cancer with high expression of CD44. Molecules. 2023;28(15):7565.
Nobahari M, Shahanipour K, Fatahian S, Monajemi R. Evaluation of cytotoxic activity of loaded catechin into iron oxide nanoparticles coated with sodium alginate and hydroxyapatite against human HT-29 colon adenocarcinoma and breast cancer MCF-7 cells. Russ J Bioorg Chem. 2023;49(7):1049–58.
Ghosh T, Das S, Das S, Paul A. Quercetin-loaded PLGA nanoparticles induce apoptosis in breast cancer cells. Mater Sci Eng C Mater Biol Appl. 2019;98:726–37.
El-Gogary RI, Nasr M, Mohamed N, Abdelkader H. Chitosan-coated, quercetin-loaded PLGA nanoparticles for enhanced anticancer activity against prostate cancer. Biomedicines. 2023;11(4):1201.
Zhou Y, Chen D, Xue G, Yu S, Yuan C, Huang M, et al. Improved therapeutic efficacy of quercetin-loaded polymeric nanoparticles on triple-negative breast cancer by inhibiting uPA. RSC Adv. 2020;10(56):34517–26.
Saha C, Kaushik A, Das A, Pal S, Majumder D. Anthracycline drugs on modified surface of quercetin-loaded polymer nanoparticles: a dual drug delivery model for cancer treatment. PLoS One. 2016;11(5):e0155710.
Khan I, Joshi G, Nakhate KT, Ajazuddin, Kumar R, Gupta U, et al. Nano-co-encapsulation of quercetin and etoposide: a synergistic strategy for cancer therapy. J Drug Deliv Sci Technol. 2021;61:102166.
Kumar D, Kumar P, Pandey A, Kumar P, Chaurasia R, Sinha MP. Development and in vitro evaluation of quercetin-loaded folic acid-conjugated PLGA nanoparticles for the treatment of breast cancer. Int J Nanomedicine. 2023;18:123–38.
Gao Y, Li Z, Sun M, Li H, Guo C, Cui J, et al. Preparation and characterization of quercetin-loaded PLGA nanoparticles for in vitro anti-cancer study. Mater Sci Eng C Mater Biol Appl. 2020;112:110923.
Wang Y, Zhao Y, Zhang F, Sun L, Bai J, Jiang F, et al. Quercetin-loaded PLGA nanoparticles: a highly effective anticancer agent in vitro and in vivo. Int J Nanomedicine. 2019;14:9059–66.
Chen X, Wang J, Chen Z, Jiang S, Wang C, Zhang Y, et al. Development of quercetin-loaded PLGA nanoparticles: a potential treatment of colorectal cancer. J Biomed Nanotechnol. 2021;17(5):828–36.
Liu Y, Zhao Y, Sun M, Chen X, Wang Y, Jiang C, et al. Quercetin-loaded PLGA nanoparticles coupled with cisplatin for enhanced anticancer efficacy in triple-negative breast cancer. J Biomed Mater Res A. 2022;110(3):735–45.
Shaheen ESGE, Anwar W, Abu-Elyazid SK, Afouna MI. Development, screening and optimization of rosuvastatin loaded nano-structured lipid carriers for improved therapeutic efficacy. Universal Journal of Pharmaceutical Research 2024; 9(5): 82-90. http://doi.org/10.22270/ujpr.v9i5.1212
Tungadi R, Jusuf H. Formulation and characterization of Astaxanthin Self Nano Emulsifying Drug Delivery System (SNEDDS). Universal Journal of Pharmaceutical Research 2022; 7(3):8-11. https://doi.org/10.22270/ujpr.v7i3.773
Nadeem A, Saqib Z, Arif A, Abid L, Shahzadi H, Saghir A, Khan E, Afzaal T, SaadatS, Rasheed N, Mustafa MA, IqbalMZ. Hybrid hydrogels incorporating nanoparticles, their types, development, and applications:A comprehensive review of nanogels. Universal Journal of Pharmaceutical Research 2024; 9(5): 142-149. http://doi.org/10.22270/ujpr.v9i5.1202
Aslam MS. Long chain polymeric carbohydrate dependent nanocomposites in tissue engineering. Universal Journal of Pharmaceutical Research 2020; 5(4):65-70. https://doi.org/10.22270/ujpr.v5i4.441
Paliwal S, Kaur G, Arya KKR. Formulation and characterization of topical nano emulgel of terbinafine. Universal Journal of Pharmaceutical Research 2018; 3(6): 28-34. https://doi.org/10.22270/ujpr.v3i6.223
Wadekar PP, Patil JA. A review on gold nanoparticles synthesis and characterization. Universal Journal of Pharmaceutical Research 2017; 2(4): 58-62. http://doi.org/10.22270/ujpr.v2i4.RW5
Sharangouda J. Patil, Banagar S.R., Banagar R.J. and Saraswati B.Patil. 2013. Chronic Effect of Phenobarbitone Administration on Uterotrophic Activity of Albino Rats. IGRL-Indo Global Research Journal of Pharmaceutical Sciences, 3, (1), 13-16.
Sharangouda and Saraswati B. Patil. 2007. Post-coital antifertility activity of Citrus medica seeds. NEA: The Bioscan- An International Journal of Life Sciences 2(4):304-310.
Sharangouda and Saraswati B. Patil. 2007. Phytochemical screening and antifertility activity of various extracts of Citrus medica (Lemon) seeds in albino rats. Connect Journals: Advances in Pharmacology and Toxicology, 8(2):71-74.
Shruti Hirekurubar, Sharangouda J. Patil and Sanjeevkumar Giri. 2022. Synthesis, Biological Evaluation and Molecular Docking of Indole Based 1,3,4-Oxadiazol Derivative, Indian Journal of Natural Sciences, 13(73): 32852-32857.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
